Home » Newsletters » BioWorld Science

BioWorld Science

July 29, 2013

View Archived Issues

Identification and suppression of the neuronal circuitry underlying compulsive behavior

Studies characterize activity of Alzheimer's disease candidate RO-4602522

Effects of AZD-5213 on sleep evaluated in patients with MCI and Alzheimer's disease

GlaxoSmithKline profiles pipeline progress of second quarter 2013

Memory improvements seen with insulin detemir in Alzheimer's disease, mild cognitive impairment

Hemophilia candidate concizumab evaluated in phase I trial

Sanofi researchers report antibodies targeting IL-13

New GPR119 receptor agonists patented by Hyundai Pharmaceutical

The Terasaki Family Foundation prepares novel IVIg mimetics

FDA grants market authorization for Cepheid's tuberculosis test

Vertex provides update on ongoing VX-135 trials in hepatitis C

Yakult Honsha begins phase I/II study of resminostat in NSCLC

EMA committee recommends Defitelio approval under exceptional circumstances

EMA's CHMP recommends approval of VEGF Trap-Eye/Eylea for new indication

PolyTherics merges with Antitope

Phosphagenics reaches milestone in development program for TPM/oxycodone patch

Genesis Biopharma and Lion Biotechnologies complete merger

EMA committee recommends approval of Revolade expanded indication

EMA issues negative opinion on delamanid for tuberculosis

Captisol-enabled topiramate injection receives FDA orphan drug status

Adimab licenses antibody discovery platform to Biogen Idec and GSK

Novartis' dual bronchodilator QVA-149 recommended for approval in COPD by CHMP

Gilead receives positive opinion from EMA for cobicistat

EMA committee recommends approval of three Takeda type 2 diabetes therapies

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 29, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 29, 2026.
Biallelic variants in COX18 identified as cause of Charcot-Marie-Tooth disease
BioWorld Science
Charcot-Marie-Tooth (CMT) disease is a group of clinically and genetically heterogeneous sensorimotor peripheral neuropathies. It is the most frequent inherited...
Brain-derived tau in blood predicts stroke severity and outcome
BioWorld Science
Brain-derived tau, a protein that is exclusive to the brain and detectable in the blood, could serve as an indicator of brain damage after an ischemic stroke. The...
Centessa’s CNT-9982 shows promise for MDD
BioWorld Science
Orexin OX2 receptor agonists have demonstrated the ability to enhance wakefulness in rodent models, as well as in nonhuman primates and patients with narcolepsy...